TP53 mutations emerge in circulating cell-free DNA obtained from patients undergoing treatment with the HDM2 antagonist SAR405838.
暂无分享,去创建一个
Joon Sang Lee | Joonil Jung | Madelyn Light | A. Cesne | G. Schwartz | E. Choy | S. Macé | M. D. Jonge | M. Dickson | R. Bahleda | A. Wagner | J. Watters